Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation [Phase 4]
Phase 4 trial assessing safety of anti-viral therapy to prevent mother-to-child transmission of hepatitis B after discontinuation in pregnan…
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver [Phase 4]
Clinical trial update for a Phase 4 study evaluating Besifovir and L-carnitine in hepatitis B patients with nonalcoholic fatty liver disease…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. [Phase 3]
Phase 3 safety trial update for a meningitis vaccine in infants following birth dose of Hepatitis B, completed.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. [Phase 3]
Phase 3 safety study evaluating a vaccine against meningitis in infants following a birth dose of hepatitis B; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B [Phase 4]
Phase 4 trial assessing long-term persistence of immunity to hepatitis B in adults vaccinated with Engerix-B (HBV) by GSK; results posted in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 trial assessing immunogenicity and safety of GSK Infanrix Hexa given at 2, 4, and 6 months in healthy infants; study completed wit…
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of GSK3389404 in healthy subjects completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay
This clinical trial update describes the collection of samples for evaluating the Aptima HBV Quant assay. The study is reported as completed…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
This clinical trial update reports the results of a study evaluating entecavir in patients with chronic hepatitis B. The results were posted…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Optimized Treatment and Regression of HBV-induced Liver Fibrosis [Phase 4]
A Phase 4 clinical trial completed that reports optimized treatment associated with regression of HBV-induced liver fibrosis.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Optimized Treatment and Regression of HBV-induced Early Cirrhosis [Phase 4]
Phase 4 trial update reports regression of HBV-related early liver cirrhosis with an optimized treatment approach.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Drug Drug Interaction Study for EYP001 With Entecavir [Phase 1]
Phase 1 drug-drug interaction study of EYP001 with Entecavir has completed. The study investigates potential interactions for chronic hepati…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases
This completed pediatric trial from Baylor College of Medicine evaluated non-invasive biomarkers to detect liver fibrosis in children with v…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy
A completed Korean cohort study evaluated tenofovir disoproxil fumarate rescue therapy in difficult-to-treat chronic hepatitis B, comparing …
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Clinical Performance Evaluation of DxN HBV Assay
A terminated clinical performance evaluation study of the DxN HBV Assay for Hepatitis B, assessing its diagnostic performance.
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1b/2a study of ABI-H0731 in patients with chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection [Phase 3]
Phase 3 trial evaluating entecavir/pegylated interferon in immune-tolerant children with chronic hepatitis B; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B [Phase 3]
Phase 3 trial investigating combination entecavir and peginterferon for HBeAg-positive immune-tolerant adults with chronic hepatitis B; stud…
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy [Phase 2]
The Phase 2 study of ARB-001467 in chronic hepatitis B patients receiving nucleos(t)ide therapy has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects [Phase 1]
A Phase 1 study evaluating the safety and pharmacokinetics of a new extended-release formulation of entecavir in healthy subjects has comple…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Characterisation of Human B Cell Maturation in Response to Vaccination
A completed clinical trial update characterising how human B cells mature in response to Hepatitis B vaccination, conducted by Imperial Coll…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Crowdsourcing to Promote HBV and HCV Testing in China [NA]
The UNC-Chapel Hill-sponsored trial NCT03482388, a crowdsourcing initiative to promote HBV and HCV testing in China, has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
This Phase 2 trial assessed RO6864018 in virologically suppressed participants with chronic hepatitis B; the study has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg [Phase 4]
This document provides a Phase 4 clinical trial update on optimizing Peginterferon alpha treatment in chronic hepatitis B patients with low …
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients [Phase 4]
This clinical trial update reports on a Phase 4 study in chronic hepatitis B patients with low replicative infection, focusing on HBsAg loss…